已确诊类风湿关节炎患者血清单己糖神经酰胺水平升高
该研究对82名参与者(包括19例已确诊RA、18例未治疗早期RA、13例未治疗早期关节炎、12例已确诊SpA和20名对照)进行血清脂质组学分析,比较各组与对照组的脂质水平。结果显示,已确诊RA患者血清鞘氨醇、单己糖神经酰胺和神经酰胺水平显著升高,其中单己糖神经酰胺在额外控制药物后仍显著升高;而SpA患者神经酰胺水平显著降低。
要点
- 已确诊RA患者血清鞘氨醇、单己糖神经酰胺和神经酰胺水平显著高于对照。
- 单己糖神经酰胺在控制年龄、性别和药物后仍显著升高。
- SpA患者神经酰胺水平显著降低。
核心结论
- 已确诊RA患者血清中某些鞘脂水平较对照可检测到升高,与既往滑液观察一致,提示鞘脂可能参与RA病理生理。
研究设计与样本
- 对82名参与者(19例已确诊RA、18例未治疗早期RA、13例未治疗早期关节炎、12例已确诊SpA、20名对照)进行血清脂质组学分析,采用多元回归分析控制诊断时年龄、性别和药物(cDMARDs和皮质激素)。
主要发现
- 已确诊RA患者血清鞘氨醇、单己糖神经酰胺和神经酰胺水平较对照显著升高(控制年龄和性别)。
- 单己糖神经酰胺水平在额外控制药物后仍显著升高。
- SpA患者神经酰胺水平在两种分析中均显著降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify serum sphingolipids that could act as candidate biomarkers in RA. METHODS: We performed lipidomic analyses in the serum of 82 participants: 19 established RA patients, 18 untreated early RA patients, 13 untreated early arthritis patients not fulfilling the classification criteria for RA, 12 established SpA patients and 20 controls. We compared the lipid levels from the different patient groups with the control group through multiple-regression analyses controlling for age at diagnosis, gender and medication (cDMARDs and corticoids). RESULTS: Established RA patients had significantly increased levels of sphingosine, monohexosylceramide and ceramide compared with controls, when controlling for age and gender. Monohexosylceramide levels remained significantly increased when additionally controlling for medication. On the contrary, SpA patients had significantly decreased levels of ceramide, in both analyses. CONCLUSION: We observed a detectable increase in the levels of certain sphingolipids in the serum of established RA patients when compared with controls, in line with previous observations in the synovial fluid. Such findings provide further evidence that sphingolipids may play a key role in the pathophysiology of RA.
引用
- Miltenberger-Miltenyi G, Cruz-Machado AR, Saville J, et al. Increased monohexosylceramide levels in the serum of established rheumatoid arthritis patients. Rheumatology (Oxford). 2020. PMID: 31808525. doi:10.1093/rheumatology/kez545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。